Biomarkers in the Development of Novel Disease-Modifying Therapies for Osteoarthritis

Bibliography

• Lawrence RC , FelsonDT, HelmickCGet al. : Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.Arthritis Rheum.58, 26–35(2008).
   PubMed Web of Science ®Google Scholar
• Brandt KD , MazzucaSA: Lessons learned from nine clinical trials of disease-modifying osteoarthritis drugs.Arthritis Rheum.52, 3349–3359(2005).
   PubMed Web of Science ®Google Scholar
• Rousseau JC , DelmasPD: Biological markers in osteoarthritis.Nat. Clin. Pract. Rheumatol.3, 346–356(2007).
   PubMedGoogle Scholar
• Bauer DC , HunterDJ, AbramsonSBet al. : Classification of osteoarthritis biomarkers: a proposed approach.Osteoarthr. Cartil.14, 723–727(2006).
   PubMed Web of Science ®Google Scholar
• King KB , LindseyCT, DunnTC, RiesMD, SteinbachLS, MajumdarS: A study of the relationship between molecular biomarkers of joint degeneration and the magnetic resonance-measured characteristics of cartilage in 16 symptomatic knees.Osteoarthr. Cartil.22, 1117–1123(2004).
   Google Scholar
• Kong SY , StablerTV, CriscioneLG, ElliottAL, JordanJM, KrausVB: Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis.Arthritis Rheum.54, 2496–2504(2006).
   PubMed Web of Science ®Google Scholar
• Conrozier T , PooleAR, FerrandFet al. : Serum concentrations of type II collagen biomarkers (C2C, C1, 2C and CPII) suggest different pathophysiologies in patients with hip osteoarthritis.Clin. Exp. Rheumatol.26, 430–435(2008).
   PubMed Web of Science ®Google Scholar
• Mazzuca SA , PooleAR, BrandtKD, KatzBP, LaneKA, LobanokT: Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis.J. Rheumatol.33, 1147–1151(2006).
   PubMed Web of Science ®Google Scholar
• Hunter DJ , LiJ, LaValleyMet al. : Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study.Arthritis Res. Ther.9, R108 (2007).
   PubMed Web of Science ®Google Scholar
• Pickering E , Szekely-KlepserG, NemirovskiyOet al. : Urinary type II collagen neoepitope (uTIINE): a marker of osteoarthritis activity.Osteoarthr. Cartil.12, S93 (2004).
   Web of Science ®Google Scholar
• Hellio Le Graverand MP , BrandtKD, MazzucaSAet al. : Association between concentrations of urinary type II collagen neoepitope (uTIINE) and joint space narrowing in patients with knee osteoarthritis.Osteoarthr. Cartil.14, 1189–1195(2006).
   PubMed Web of Science ®Google Scholar
• Otterness IG , BrandtKD, Le Graverand MP, Mazzuca SA: Urinary TIINE concentrations in a randomized controlled trial of doxycycline in knee osteoarthritis: implications of the lack of association between TIINE levels and joint space narrowing. Arthritis Rheum.56, 3644–3649(2007).
   PubMedGoogle Scholar
• Deberg M , DubucJE, LabasseAet al. : One-year follow-up of Coll2–1, Coll2–1NO2 and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement.Ann. Rheum. Dis.67, 168–174(2008).
   PubMed Web of Science ®Google Scholar
• Deberg M , LabasseA, ChristgauSet al. : New serum biochemical markers (Coll 2–1 and Coll 2–1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis.Osteoarthr. Cartil.13, 258–265(2005).
   PubMed Web of Science ®Google Scholar
• Henrotin Y , DebergM, DubucJE, QuettierE, ChristgauS, ReginsterJY: Type II collagen peptides for measuring cartilage degradation.Biorheology41, 543–547(2004).
   PubMed Web of Science ®Google Scholar
• Deberg MA , LabasseAH, ColletteJ, SeidelL, ReginsterJY, HenrotinYE: One-year increase of Coll 2–1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression.Osteoarthr. Cartil.13, 1059–1065(2005).
   PubMed Web of Science ®Google Scholar
• Charni N , JuilletF, GarneroP: Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.Arthritis Rheum.52, 1081–1090(2005).
   PubMed Web of Science ®Google Scholar
• Garnero P , CharniN, JuilletF, ConrozierT, VignonE: Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis.Ann. Rheum. Dis.65, 1639–1644(2006).
   PubMed Web of Science ®Google Scholar
• Quintana DJ , GarneroP, HuebnerJL, Charni-Ben Tabassi N, Kraus VB: PIIANP and HELIXII diurnal variation. Osteoarthr. Cartil.16(10), 1192–1195(2008).
   PubMed Web of Science ®Google Scholar
• Aurich M , PooleAR, ReinerAet al. : Matrix homeostasis in aging normal human ankle cartilage.Arthritis Rheum.46, 2903–2910(2002).
   PubMed Web of Science ®Google Scholar
• Hollander AP , PidouxI, ReinerA, RorabeckC, BourneRA, PooleR: Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration.J. Clin. Invest.96, 2859–2869(1995).
   PubMed Web of Science ®Google Scholar
• Garnero P , PipernoM, GineytsE, ChristgauS, DelmasPD, VignonE: Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.Ann. Rheum. Dis.60, 619–626(2001).
   PubMed Web of Science ®Google Scholar
• Garnero P , ConrozierT, ChristgauS, MathieuP, DelmasPD, VignonE: Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis.Ann. Rheum. Dis.62, 939–943(2003).
   PubMed Web of Science ®Google Scholar
• Reijman M , HazesJM, Bierma-ZeinstraSMet al. : A new marker for osteoarthritis: cross-sectional and longitudinal approach.Arthritis Rheum.50, 2471–2478(2004).
   PubMed Web of Science ®Google Scholar
• Jordan KM , SyddallHE, GarneroPet al. : Urinary CTX-II and glucosyl–galactosyl–pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men.Ann. Rheum. Dis.65, 871–877(2006).
   PubMed Web of Science ®Google Scholar
• Dam EB , ByrjalsenI, KarsdalMA, QvistP, ChristiansenC: Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.Osteoarthr. Cartil. (2008) (Epub ahead of print).
   Google Scholar
• Garnero P , MazieresB, GueguenAet al. : Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort.J. Rheumatol.32, 697–703(2005).
   PubMed Web of Science ®Google Scholar
• Mazieres B , HucherM, ZaimM, GarneroP: Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study.Ann. Rheum. Dis.66, 639–645(2007).
   PubMed Web of Science ®Google Scholar
• Bruyere O , ColletteJ, KothariMet al. : Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study.Ann. Rheum. Dis.65, 1050–1054(2006).
   PubMed Web of Science ®Google Scholar
• Sharif M , KirwanJ, CharniN, SandellLJ, WhittlesC, GarneroP: A 5-year longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis: association with disease progression.Rheumatology (Oxford)46, 938–943(2007).
   PubMed Web of Science ®Google Scholar
• Garnero P , AronsteinWS, CohenSBet al. : Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.Osteoarthr. Cartil.16, 660–666(2008).
   PubMed Web of Science ®Google Scholar
• Mazzuca SA , BrandtKD, EyreDR, KatzBP, AskewJ, LaneKA: Urinary levels of type II collagen C-telopeptide crosslink are unrelated to joint space narrowing in patients with knee osteoarthritis.Ann. Rheum. Dis.65, 1055–1059(2006).
   PubMed Web of Science ®Google Scholar
• Henrotin Y , AddisonS, KrausV, DebergM: Type II collagen markers in osteoarthritis: what do they indicate?Curr. Opin. Rheumatol.19, 444–450(2007).
   PubMed Web of Science ®Google Scholar
• van der Rest M , GarroneR: Collagen family of proteins.FASEB J.5, 2814–2823(1991).
   PubMed Web of Science ®Google Scholar
• Garnero P , AyralX, RousseauJCet al. : Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.Arthritis Rheum.46, 2613–2624(2002).
   PubMed Web of Science ®Google Scholar
• Rousseau JC , ZhuY, MiossecPet al. : Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis.Osteoarthr. Cartil.12, 440–447(2004).
   PubMed Web of Science ®Google Scholar
• Rousseau JC , SandellLJ, DelmasPD, GarneroP: Development and clinical application in arthritis of a new immunoassay for serum type IIA procollagen NH2 propeptide.Methods Mol. Med.101, 25–37(2004).
   PubMedGoogle Scholar
• Chen HC , ShahS, StablerTV, LiYJ, KrausVB: Biomarkers associated with clinical phenotypes of hand osteoarthritis in a large multigenerational family: the CARRIAGE family study.Osteoarthr. Cartil.16(9), 1054–1059(2008).
   PubMed Web of Science ®Google Scholar
• Lohmander LS , YoshiharaY, RoosH, KobayashiT, YamadaH, ShinmeiM: Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis.J. Rheumatol.23, 1765–1769(1996).
   PubMed Web of Science ®Google Scholar
• Kobayashi T , YoshiharaY, SamuraAet al. : Synovial fluid concentrations of the C-propeptide of type II collagen correlate with body mass index in primary knee osteoarthritis.Ann. Rheum. Dis.56, 500–503(1997).
   PubMed Web of Science ®Google Scholar
• Sugiyama S , ItokazuM, SuzukiY, ShimizuK: Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis.Ann. Rheum. Dis.62, 27–32(2003).
   PubMed Web of Science ®Google Scholar
• Elsaid KA , ChichesterCO: Review: collagen markers in early arthritic diseases.Clin. Chim. Acta365, 68–77(2006).
   PubMed Web of Science ®Google Scholar
• Carter QL , DotzlafJ, SwearingenCet al. : Development and characterization of a novel ELISA based assay for the quantitation of sub-nanomolar levels of neoepitope exposed NITEGE-containing aggrecan fragments.J. Immunol. Methods328, 162–168(2007).
   PubMed Web of Science ®Google Scholar
• Glasson SS , AskewR, SheppardBet al. : Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis.Nature434, 644–648(2005).
   PubMed Web of Science ®Google Scholar
• Stanton H , RogersonFM, EastCJet al. : ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro.Nature434, 648–652(2005).
   PubMed Web of Science ®Google Scholar
• Fosang AJ , RogersonFM, EastCJ, StantonH: ADAMTS-5: the story so far.Eur. Cell. Mater.15, 11–26(2008).
   PubMed Web of Science ®Google Scholar
• Lark MW , BayneEK, FlanaganJet al. : Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.J. Clin. Invest.100, 93–106(1997).
   PubMed Web of Science ®Google Scholar
• Struglics A , LarssonS, PrattaMA, KumarS, LarkMW, LohmanderLS: Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.Osteoarthr. Cartil.14, 101–113(2006).
   PubMed Web of Science ®Google Scholar
• Malfait AM , LiuRQ, IjiriK, KomiyaS, TortorellaMD: Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage.J. Biol. Chem.277, 22201–22208(2002).
   PubMed Web of Science ®Google Scholar
• Sandy JD , FlanneryCR, NeamePJ, LohmanderLS: The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373–Ala 374 bond of the interglobular domain.J. Clin. Invest.89, 1512–1516(1992).
   PubMed Web of Science ®Google Scholar
• Pratta MA , SuJL, LeesnitzerMAet al. : Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments.Osteoarthr. Cartil.14, 702–713(2006).
   PubMed Web of Science ®Google Scholar
• Rizkalla G , ReinerA, BogochE, PooleAR: Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease.J. Clin. Invest.90, 2268–2277(1992).
   PubMed Web of Science ®Google Scholar
• Poole AR , IonescuM, SwanA, DieppePA: Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis.J. Clin. Invest.94, 25–33(1994).
   PubMed Web of Science ®Google Scholar
• Lohmander LS , IonescuM, JugessurH, PooleAR: Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.Arthritis Rheum.42, 534–544(1999).
   PubMedGoogle Scholar
• Aurich M , SquiresGR, ReinerAet al. : Differential matrix degradation and turnover in early cartilage lesions of human knee and ankle joints.Arthritis Rheum.52, 112–119(2005).
   PubMedGoogle Scholar
• Ishiguro N , ItoT, ItoHet al. : Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis.Arthritis Rheum.42, 129–136(1999).
   PubMedGoogle Scholar
• Pothacharoen P , TeekachunhateanS, LouthrenooWet al. : Raised chondroitin sulfate epitopes and hyaluronan in serum from rheumatoid arthritis and osteoarthritis patients.Osteoarthr. Cartil.14, 299–301(2006).
   PubMed Web of Science ®Google Scholar
• Fawthrop F , YaqubR, BelcherC, BaylissM, LedinghamJ, DohertyM: Chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in progressive versus non-progressive osteoarthritis.Ann. Rheum. Dis.56, 119–122(1997).
   PubMed Web of Science ®Google Scholar
• Vilim V , OlejarovaM, MachacekS, GatterovaJ, KrausVB, PavelkaK: Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis.Osteoarthr. Cartil.10, 707–713(2002).
   PubMed Web of Science ®Google Scholar
• Sharif M , SaxneT, ShepstoneLet al. : Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint.Br. J. Rheumatol.34, 306–310(1995).
   PubMedGoogle Scholar
• Clark AG , JordanJM, VilimVet al. : Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project.Arthritis Rheum.42, 2356–2364(1999).
   PubMed Web of Science ®Google Scholar
• Senolt L , BraunM, OlejarovaM, ForejtovaS, GatterovaJ, PavelkaK: Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.Ann. Rheum. Dis.64, 886–890(2005).
   PubMed Web of Science ®Google Scholar
• Chaganti RK , KelmanA, LuiLet al. : Change in serum measurements of cartilage oligomeric matrix protein and association with the development and worsening of radiographic hip osteoarthritis.Osteoarthr. Cartil.16(5), 566–571(2007).
   PubMed Web of Science ®Google Scholar
• Kelman A , LuiL, YaoW, KrummeA, NevittM, LaneNE: Association of higher levels of serum cartilage oligomeric matrix protein and N-telopeptide crosslinks with the development of radiographic hip osteoarthritis in elderly women.Arthritis Rheum.54, 236–243(2006).
   PubMedGoogle Scholar
• Fernandes FA , PucinelliML, da Silva NP, Feldman D: Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation. Scand. J. Rheumatol.36, 211–215(2007).
   PubMed Web of Science ®Google Scholar
• Petersson IF , BoegardT, SvenssonB, HeinegardD, SaxneT: Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint.Br. J. Rheumatol.37, 46–50(1998).
   PubMedGoogle Scholar
• Jung YO , DoJH, KangHJet al. : Correlation of sonographic severity with biochemical markers of synovium and cartilage in knee osteoarthritis patients.Clin. Exp. Rheumatol.24, 253–259(2006).
   PubMed Web of Science ®Google Scholar
• Meulenbelt I , KloppenburgM, KroonHMet al. : Clusters of biochemical markers are associated with radiographic subtypes of osteoarthritis (OA) in subject with familial OA at multiple sites. The GARP study.Osteoarthr. Cartil.15, 379–385(2007).
   PubMed Web of Science ®Google Scholar
• Recklies AD , BaillargeonL, WhiteC: Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes.Arthritis Rheum.41, 997–1006(1998).
   PubMedGoogle Scholar
• Vilim V , VytasekR, OlejarovaMet al. : Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis.Osteoarthr. Cartil.9, 612–618(2001).
   PubMed Web of Science ®Google Scholar
• Pullig O , WeselohG, RonnebergerD, KakonenS, SwobodaB: Chondrocyte differentiation in human osteoarthritis: expression of osteocalcin in normal and osteoarthritic cartilage and bone.Calcif. Tissue Int.67, 230–240(2000).
   PubMed Web of Science ®Google Scholar
• Jiang LS , ZhangZM, JiangSD, ChenWH, DaiLY: Differential bone metabolism between postmenopausal women with osteoarthritis and osteoporosis.J. Bone Miner. Res.23, 475–483(2008).
   PubMed Web of Science ®Google Scholar
• Stewart A , BlackA, RobinsSP, ReidDM: Bone density and bone turnover in patients with osteoarthritis and osteoporosis.J. Rheumatol.26, 622–626(1999).
   PubMed Web of Science ®Google Scholar
• Campion GV , DelmasPD, DieppePA: Serum and synovial fluid osteocalcin (bone gla protein) levels in joint disease.Br. J. Rheumatol.28, 393–398(1989).
   PubMedGoogle Scholar
• Sowers M , LachanceL, JamadarDet al. : The associations of bone mineral density and bone turnover markers with osteoarthritis of the hand and knee in pre- and perimenopausal women.Arthritis Rheum.42, 483–489(1999).
   PubMedGoogle Scholar
• Wang Y , EbelingPR, HannaF, O‘SullivanR, CicuttiniFM: Relationship between bone markers and knee cartilage volume in healthy men.J. Rheumatol.32, 2200–2204(2005).
   PubMed Web of Science ®Google Scholar
• Bruyere O , ColletteJH, EthgenOet al. : Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis.J. Rheumatol.30, 1043–1050(2003).
   PubMed Web of Science ®Google Scholar
• Berger CE , KronerA, StieglerH, LeithaT, EngelA: Elevated levels of serum type I collagen C-telopeptide in patients with rapidly destructive osteoarthritis of the hip.Int. Orthop.29, 1–5(2005).
   PubMed Web of Science ®Google Scholar
• Withold W , SchulteU, ReinauerH: Method for determination of bone alkaline phosphatase activity: analytical performance and clinical usefulness in patients with metabolic and malignant bone diseases.Clin. Chem.42, 210–217(1996).
   PubMed Web of Science ®Google Scholar
• Jenkins DK : Review series: bone alkaline phosphatase, a serum bone turnover assay: usefulness in managing postmenopausal women receiving threrapy to prevent or treat osteoporosis. Quidel Corporation, CA, USA (2001).
   Google Scholar
• El Miedany YM , MehannaAN, El Baddini MA: Altered bone mineral metabolism in patients with osteoarthritis. Joint Bone Spine67, 521–527(2000).
   PubMed Web of Science ®Google Scholar
• Seibel MJ , DuncanA, RobinsSP: Urinary hydroxy–pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases.J. Rheumatol.16, 964–970(1989).
   PubMed Web of Science ®Google Scholar
• Spacek P , AdamM: Pentosidine in osteoarthritis: HPLC determination in body fluids and in tissues.Rheumatol. Int.26, 923–927(2006).
   PubMed Web of Science ®Google Scholar
• Abe M , TakahashiM, NaitouK, OhmuraK, NaganoA: Investigation of generalized osteoarthritis by combining X-ray grading of the knee, spine and hand using biochemical markers for arthritis in patients with knee osteoarthritis.Clin. Rheumatol.22, 425–431(2003).
   PubMed Web of Science ®Google Scholar
• Takahashi M , NaitoK, AbeM, SawadaT, NaganoA: Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis.Arthritis Res. Ther.6, R208–R212 (2004).
   PubMed Web of Science ®Google Scholar
• Bank RA , VerzijlN, LafeberFP, TekoppeleJM: Putative role of lysyl hydroxylation and pyridinoline cross-linking during adolescence in the occurrence of osteoarthritis at old age.Osteoarthr. Cartil.10, 127–134(2002).
   PubMed Web of Science ®Google Scholar
• Graverand MP , TronAM, IchouMet al. : Assessment of urinary hydroxypyridinium cross-links measurement in osteoarthritis.Br. J. Rheumatol.35, 1091–1095(1996).
   PubMedGoogle Scholar
• Rovetta G , MonteforteP, GrignoloMC, BrignoneA, BuffriniL: Hematic levels of type I collagen C-telopeptide in erosive versus nonerosive osteoarthritis of the hands.Int. J. Tissue React.25, 25–28(2003).
   PubMedGoogle Scholar
• Naitou K , KushidaK, TakahashiM, OhishiT, InoueT: Bone mineral density and bone turnover in patients with knee osteoarthritis compared with generalized osteoarthritis.Calcif. Tissue Int.66, 325–329(2000).
   PubMed Web of Science ®Google Scholar
• Withold W , ArmbrusterFP, KarmatschekM, ReinauerH: Bone sialoprotein in serum of patients with malignant bone diseases.Clin. Chem.43, 85–91(1997).
   PubMed Web of Science ®Google Scholar
• Conrozier T , SaxneT, FanCSet al. : Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study.Ann. Rheum. Dis.57, 527–532(1998).
   PubMed Web of Science ®Google Scholar
• Elliott AL , KrausVB, LutaGet al. : Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project.Arthritis Rheum.52, 105–111(2005).
   PubMed Web of Science ®Google Scholar
• Chua SD Jr, Messier SP, Legault C, Lenz ME, Thonar EJ, Loeser RF: Effect of an exercise and dietary intervention on serum biomarkers in overweight and obese adults with osteoarthritis of the knee. Osteoarthr. Cartil.16(9), 1047–1053(2008).
   PubMed Web of Science ®Google Scholar
• Belo JN , BergerMY, ReijmanM, KoesBW, Bierma-ZeinstraSM: Prognostic factors of progression of osteoarthritis of the knee: a systematic review of observational studies.Arthritis Rheum.57, 13–26(2007).
   PubMedGoogle Scholar
• Mazieres B , GarneroP, GueguenAet al. : Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort.Ann. Rheum. Dis.65, 354–359(2006).
   PubMed Web of Science ®Google Scholar
• Gineyts E , GarneroP, DelmasPD: Urinary excretion of glucosyl–galactosyl pyridinoline: a specific biochemical marker of synovium degradation.Rheumatology (Oxford)40, 315–323(2001).
   PubMed Web of Science ®Google Scholar
• Gineyts E , MoJA, KoAet al. : Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis.Ann. Rheum. Dis.63, 857–861(2004).
   PubMed Web of Science ®Google Scholar
• Rathcke CN , VestergaardH: YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis.Inflamm. Res.55, 221–227(2006).
   PubMed Web of Science ®Google Scholar
• Volck B , JohansenJS, StoltenbergMet al. : Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology.Osteoarthr. Cartil.9, 203–214(2001).
   PubMed Web of Science ®Google Scholar
• Conrozier T , CarlierMC, MathieuPet al. : Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study.Ann. Rheum. Dis.59, 828–831(2000).
   PubMed Web of Science ®Google Scholar
• Pavelka K , ForejtovaS, OlejarovaMet al. : Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis.Osteoarthr. Cartil.12, 277–283(2004).
   PubMed Web of Science ®Google Scholar
• Lamers RJ , van NesselrooijJH, KrausVBet al.: Identification of an urinary metabolite profile associated with osteoarthritis. Osteoarthr. Cartil.13, 762–768(2005).
   PubMed Web of Science ®Google Scholar
• Hunter DJ , ConaghanPG: Imaging outcomes and their role in determining outcomes in osteoarthritis and rheumatoid arthritis.Curr. Opin. Rheumatol.18, 157–162(2006).
   PubMed Web of Science ®Google Scholar
• Hunter DJ , ZhangY, NiuJet al. : Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis.Arthritis Rheum.54, 1529–1535(2006).
   PubMed Web of Science ®Google Scholar
• Eckstein F , CicuttiniF, RaynauldJP, WatertonJC, PeterfyC: Magnetic resonance imaging (MRI) of articular cartilage in knee osteoarthritis (OA): morphological assessment.Osteoarthr. Cartil.14(Suppl. A), A46–A75 (2006).
   PubMedGoogle Scholar
• Burstein D , GrayML: Is MRI fulfilling its promise for molecular imaging of cartilage in arthritis?Osteoarthr. Cartil.14, 1087–1090(2006).
   PubMed Web of Science ®Google Scholar
• Eckstein F , BursteinD, LinkTM: Quantitative MRI of cartilage and bone: degenerative changes in osteoarthritis.NMR Biomed.19, 822–854(2006).
   PubMed Web of Science ®Google Scholar
• Wheaton AJ , BorthakurA, DodgeGR, KneelandJB, SchumacherHR, ReddyR: Sodium magnetic resonance imaging of proteoglycan depletion in an in vivo model of osteoarthritis.Acad. Radiol.11, 21–28(2004).
   PubMed Web of Science ®Google Scholar
• Borthakur A , MellonE, NiyogiS, WitscheyW, KneelandJB, ReddyR: Sodium and T1r MRI for molecular and diagnostic imaging of articular cartilage.NMR Biomed.19, 781–821(2006).
   PubMed Web of Science ®Google Scholar
• Shapiro EM , BorthakurA, GougoutasA, ReddyR: 23Na MRI accurately measures fixed charge density in articular cartilage.Magn. Reson. Med.47, 284–291(2002).
   PubMed Web of Science ®Google Scholar
• Burstein D : MRI for development of disease-modifying osteoarthritis drugs.NMR Biomed.19, 669–680(2006).
   PubMed Web of Science ®Google Scholar
• Tiderius CJ , OlssonLE, LeanderP, EkbergO, DahlbergL: Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in early knee osteoarthritis.Magn. Reson. Med.49, 488–492(2003).
   PubMed Web of Science ®Google Scholar
• Williams A , SharmaL, McKenzieCA, PrasadPV, BursteinD: Delayed gadolinium-enhanced magnetic resonance imaging of cartilage in knee osteoarthritis: findings at different radiographic stages of disease and relationship to malalignment.Arthritis Rheum.52, 3528–3535(2005).
   PubMed Web of Science ®Google Scholar